-
Mashup Score: 26
EHA Library; Desai N. Jun 13 2024; 419406;
Source: library.ehaweb.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 25
EHA Library; Desai N. Jun 13 2024; 419429;
Source: library.ehaweb.orgCategories: General Medicine News, Hem/OncsTweet-
Excited to present our real-world data of Belumosudil for cGVHD at the @EHA_Hematology annual meeting in Madrid this June. This is definitely a promising drug for our patients💪🏻 @Hans_BMTProgram @pmcancercentre @Haemophage @IvanPasic #MedTwitter https://t.co/MsBK3EmkMS
-
-
Mashup Score: 24TIMING AND OUTCOMES OF SECOND LINE THERAPY IN THE ERA OF... by Abdul-Hamid Bazarbachi - 6 month(s) ago
EHA Library; Bazarbachi A. Jun 13 2024; 421013;
Source: library.ehaweb.orgCategories: General Medicine News, Partners & KOLsTweet-
Timing and Outcomes of 2nd line therapy in the era of frontline Dara-VCd in AL #Amyloidosis-Our experience @CAMPamyloidosis to be presented at #EHA24 by @abazarbachi! @SLentzsch https://t.co/6o7lBqkzR8
-
-
Mashup Score: 5
EHA Library; Dhakal B. Jun 13 2024; 420962;
Source: library.ehaweb.orgCategories: General Medicine News, Hem/OncsTweet-
SONROTOCLAX PLUS DEXAMETHASONE IS TOLERABLE AND DEM... by Binod Dhakal EHA Library; Jun 13 2024; 420962 https://t.co/MOaK5zVS8e
-
-
Mashup Score: 3
EHA Library; Du J. Jun 13 2024; 421005;
Source: library.ehaweb.orgCategories: General Medicine News, Hem/OncsTweet-
FIRST-IN-HUMAN STUDY OF GPRC5D-TARGETED CAR T CELLS... by Juan Du EHA Library; Jun 13 2024; 421005 https://t.co/iEM3TI44eg
-
-
Mashup Score: 12DARATUMUMAB (DARA) + BORTEZOMIB/THALIDOMIDE/DEXAMETHASONE (D-VTD)... by Prof. Philippe Moreau - 6 month(s) ago
EHA Library; Moreau P. Jun 13 2024; 422308;
Source: library.ehaweb.orgCategories: General Medicine News, Hem/OncsTweet-
@End_myeloma @MyelomaTeacher @Rfonsi1 @VincentRK @DrOlaLandgren Here's the link for the updated results of CASSIOPEIA https://t.co/1eXs2r1Amu
-
-
Mashup Score: 52PRE-ALLOGENEIC TRANSPLANTATION FLOW CYTOMETRY TESTING FOR PATIENTS... by Firas El Chaer - 6 month(s) ago
EHA Library; El Chaer F. Jun 13 2024; 422362;
Source: library.ehaweb.orgCategories: General Medicine News, Hem/OncsTweet-
I am excited to present this oral presentation at @EHA_Hematology on the value of MRD in AML **as it is currently performed** from the @CIBMTR database @page_md @DrChrisHourigan https://t.co/noSD15XLuy
-
-
Mashup Score: 69PRIMARY RESULTS OF THE PHASE III STIMULUS-MDS2 STUDY OF SABATOLIMAB... by Amer M. Zeidan - 6 month(s) ago
EHA Library; Zeidan A. Jun 13 2024; 422284;
Source: library.ehaweb.orgCategories: General Medicine News, Hem/OncsTweet-
This is the closest we ever got to improving survival in a randomized Phase 3 trial for higher risk #MDSsm. Can’t describe the disappointment when p-value came at 0.08, but I look forward to presenting data in #EHA2024, & I still believe in TIM3 targeting https://t.co/ZJE3bQdody
-
-
Mashup Score: 48PHASE 1B STUDY OF AZACITIDINE, VENETOCLAX AND REVUMENIB IN NEWLY... by Dr. Joshua Zeidner - 6 month(s) ago
EHA Library; Zeidner J. Jun 13 2024; 422238;
Source: library.ehaweb.orgCategories: General Medicine News, Hem/OncsTweet-
Looking forward to presenting a phase 1 study of Azacitidine, Venetoclax and Revumenib in newly Dx AML w/ NPM1 mut or KMT2A rearrangement @EHA_Hematology. Can’t wait for the exciting Menin Inhibitor oral Session! @LLSusa @UNC_Lineberger https://t.co/Fwg3r30s2n
-
-
Mashup Score: 1GLOBAL RATES OF INFLUENZA (FV) AND PNEUMOCOCCAL (PV) VACCINATION IN... by Dr. Michael A. Thompson - 7 month(s) ago
EHA Library; A. Thompson M. Jun 12 2020; 294884;
Source: library.ehaweb.orgCategories: General Medicine News, Hem/OncsTweet-
Global rates of influenza (FV) & pneumococcal (PV) vax in MM: Impact on HRU & OS [6/12/20] @mtmdphd et al. Abs EP967 #EHA25 https://t.co/lB14KmSH9S #mmsm #IDonc Multivariate analysis - FV & PV significantly impacted OS when adjusted for age, region, and ECOG PS (Table)
-
Excited to report outcomes of patients undergoing SECOND ALLOGENEIC TRANSPLANT for GRAFT FAILURE using the "one day conditioning" regimen! #MedTwitter @Haemophage @IvanPasic @pmcancercentre @Hans_BMTProgram https://t.co/WxOEzfo2BE